Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping.

Drouot E, Piret J, Lebel MH, Boivin G.

J Clin Microbiol. 2014 Nov;52(11):4043-6. doi: 10.1128/JCM.02205-14. Epub 2014 Aug 20.

2.

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.

Choi SH, Hwang JY, Park KS, Kim Y, Lee SH, Yoo KH, Kang ES, Ahn JH, Sung KW, Koo HH, Kim YJ.

Transpl Infect Dis. 2014 Dec;16(6):919-29. doi: 10.1111/tid.12311. Epub 2014 Nov 18.

PMID:
25405808
3.

Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.

Göhring K, Wolf D, Bethge W, Mikeler E, Faul C, Vogel W, Vöhringer MC, Jahn G, Hamprecht K.

J Clin Virol. 2013 May;57(1):43-9. doi: 10.1016/j.jcv.2013.01.003. Epub 2013 Jan 30.

PMID:
23375740
4.

Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.

Schnepf N, Dhédin N, Mercier-Delarue S, Andreoli A, Mamez AC, Ferry C, Deback C, Ribaud P, Robin M, Socié G, Simon F, Mazeron MC.

J Clin Virol. 2013 Dec;58(4):733-6. doi: 10.1016/j.jcv.2013.10.007. Epub 2013 Oct 16.

PMID:
24183928
5.

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.

Iwasenko JM, Scott GM, Naing Z, Glanville AR, Rawlinson WD.

Transpl Infect Dis. 2011 Apr;13(2):145-53. doi: 10.1111/j.1399-3062.2010.00584.x. Epub 2010 Nov 10.

PMID:
21070537
6.

Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene.

Martin M, Goyette N, Boivin G.

J Clin Virol. 2010 Dec;49(4):296-8. doi: 10.1016/j.jcv.2010.08.008. Epub 2010 Sep 16.

PMID:
20843736
7.

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.

Hantz S, Garnier-Geoffroy F, Mazeron MC, Garrigue I, Merville P, Mengelle C, Rostaing L, Saint Marcoux F, Essig M, Rerolle JP, Cotin S, Germi R, Pillet S, Lebranchu Y, Turlure P, Alain S; French CMV Resistance Survey Study Group.

J Antimicrob Chemother. 2010 Dec;65(12):2628-40. doi: 10.1093/jac/dkq368. Epub 2010 Oct 20.

PMID:
20961907
8.

Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.

Campos AB, Ribeiro J, Boutolleau D, Sousa H.

Rev Med Virol. 2016 May;26(3):161-82. doi: 10.1002/rmv.1873. Epub 2016 Mar 14. Review.

PMID:
26990717
9.

Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.

Fischer L, Sampaio KL, Jahn G, Hamprecht K, Göhring K.

J Clin Virol. 2015 Aug;69:150-5. doi: 10.1016/j.jcv.2015.06.090. Epub 2015 Jun 19.

PMID:
26209398
10.

Rapid detection of human cytomegalovirus UL97 and UL54 mutations for antiviral resistance in clinical specimens.

Daikoku T, Saito K, Aihara T, Ikeda M, Takahashi Y, Hosoi H, Nishida T, Takemoto M, Shiraki K.

Microbiol Immunol. 2013 May;57(5):396-9. doi: 10.1111/1348-0421.12043.

11.

A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.

Zhang Y, Zhao Z, Sun J, Cao G, Zhao F, Hu J, Liu L, Ji Y.

Arch Virol. 2013 Jan;158(1):247-50. doi: 10.1007/s00705-012-1479-4. Epub 2012 Sep 26.

PMID:
23011309
12.

Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.

Scott GM, Isaacs MA, Zeng F, Kesson AM, Rawlinson WD.

J Med Virol. 2004 Sep;74(1):85-93.

PMID:
15258973
13.

Approach to drug-resistant cytomegalovirus in transplant recipients.

Chou S.

Curr Opin Infect Dis. 2015 Aug;28(4):293-9. doi: 10.1097/QCO.0000000000000170. Review.

14.

Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.

Fischer L, Laib Sampaio K, Jahn G, Hamprecht K, Göhring K.

Antiviral Res. 2013 Dec;100(3):575-7. doi: 10.1016/j.antiviral.2013.09.026. Epub 2013 Oct 10.

PMID:
24120366
15.

Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient.

Jeong TD, Sung H, Choi SH, Lee SO, Yoon HK, Kim MN, Im HJ.

Diagn Microbiol Infect Dis. 2012 Nov;74(3):307-10. doi: 10.1016/j.diagmicrobio.2012.07.006. Epub 2012 Aug 24.

PMID:
22921815
16.
17.

UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease.

Gregg K, Hakki M, Kaul DR.

Transpl Infect Dis. 2014 Apr;16(2):320-3. doi: 10.1111/tid.12200. Epub 2014 Mar 13.

18.

Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.

Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.

J Med Virol. 2008 Oct;80(10):1769-75. doi: 10.1002/jmv.21277.

PMID:
18712833
19.

[Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].

Vejražková E, Hubáček P, Kutová R, Plíšková L, Košťál M, Štěpánová V, Zavřelová A, Radocha J, Malá E, Žák P.

Epidemiol Mikrobiol Imunol. 2015 Sep;64(3):160-8. Czech.

PMID:
26448304
20.

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.

Kleiboeker S, Nutt J, Schindel B, Dannehl J, Hester J.

Transpl Infect Dis. 2014 Aug;16(4):561-7. doi: 10.1111/tid.12241. Epub 2014 Jun 5.

PMID:
24903568

Supplemental Content

Support Center